SCHEMBL16620022

SCHEMBL16620022

CCN1CCN(Cc2ccc(NC(=O)O)cc2Cl)CC1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.56
MEN1 O00255 1/20 0.56
CYP2C19 P33261 1/20 0.56
KMT2A Q03164 1/20 0.56
NPC1 O15118 4/20 0.55
RAB9A P51151 4/20 0.55
TP53 P04637 2/20 0.55
POLB P06746 1/20 0.55
CHRM1 P11229 5/20 0.54
CHRM2 P08172 1/20 0.53
CHRM4 P08173 1/20 0.53
SMN1; SMN2 Q16637 4/20 0.52
CYP2C9 P11712 1/20 0.52
LMNA P02545 2/20 0.51
CHRM5 P08912 3/20 0.50
CHRM3 P20309 2/20 0.50
MAPT P10636 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25292715 0.90 ABL1 (0.57) TP53POLB
SCHEMBL16620422 0.85 EPHX2 (0.54) CYP2D6MEN1CYP2C19KMT2ANPC1
SCHEMBL16629103 0.84 POLB (0.55) CYP2D6MEN1CYP2C19KMT2ANPC1
SCHEMBL27088109 0.81 RET (0.64)
SCHEMBL29581481 0.80 RAB9A (0.76) NPC1RAB9ATP53POLBSMN1; SMN2
SCHEMBL4935491 0.76 KDR (0.65) NPC1RAB9ATP53POLBSMN1; SMN2
SCHEMBL16380773 0.76 IP6K1 (0.56) NPC1RAB9ATP53POLBSMN1; SMN2
SCHEMBL25802168 0.74 GAA (0.57) NPC1RAB9APOLBSMN1; SMN2LMNA
SCHEMBL23213588 0.74 ABL1 (0.49) MEN1KMT2ATP53POLBMAPT
SCHEMBL25245565 0.74 LMNA (0.56) MEN1KMT2ALMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015049325-A1 THERAPEUTIC INHIBITORS OF CDK8 AND USES THEREOF F. HOFFMANN-LA ROCHE AG (CH) 2015-04-09 WO disclosed
US-20150045255-A1 Endometrial Phase or Endometrial Cancer Biomarkers WALFISH, PAUL (CA) 2015-02-12 US disclosed